Literature DB >> 2893828

A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled.

R W Steketee1, D G Burstyn, S G Wassilak, W N Adkins, M B Polyak, J P Davis, C R Manclark.   

Abstract

During a pertussis outbreak in a facility for the developmentally disabled, culture- or direct fluorescent-antibody-confirmed cases were identified in 24 residents and 17 staff members; 38 (93%) were culture positive for Bordetella pertussis. An enzyme-linked immunosorbent assay (ELISA) was used to detect serum IgG and IgA to the filamentous hemagglutinin and lymphocytosis-promoting factor of B. pertussis. Using criteria from ELISA values, we identified an additional 83 residents and 28 staff members as seropositive. Among seropositive persons, antibody levels were elevated by the time of onset of respiratory symptoms and, in three of the four assays, remained elevated for 14 mo. In 44 seropositive persons tested within two weeks of onset of symptoms, 80% were culture positive, compared with 33% of 15 tested two to four weeks after onset (P = .003) and none of 15 tested more than four weeks after onset. The most specific (94%) clinical case definition identified only 41% of seropositive persons. Thus, ELISAs are important tools for individual diagnosis and epidemiological studies of pertussis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893828     DOI: 10.1093/infdis/157.3.441

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

Authors:  H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Pertussis in adults with persistent cough in South Korea.

Authors:  W B Park; S W Park; H B Kim; E C Kim; M Oh; K W Choe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

Review 3.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

4.  Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis.

Authors:  C M Mink; C H O'Brien; S Wassilak; A Deforest; B D Meade
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

5.  Detection of Bordetella pertussis by rapid-cycle PCR and colorimetric microwell hybridization.

Authors:  G E Buck
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

Review 6.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

7.  Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis.

Authors:  S A Halperin; R Bortolussi; A J Wort
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

8.  Sensitivity and specificity of clinical case definitions for pertussis.

Authors:  P A Patriarca; R J Biellik; G Sanden; D G Burstyn; P D Mitchell; P R Silverman; J P Davis; C R Manclark
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

9.  Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussis.

Authors:  S A Halperin; R Bortolussi; A Kasina; A J Wort
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

10.  Diagnosis of community-acquired pertussis infection: comparison of both culture and fluorescent-antibody assays with PCR detection using electrophoresis or dot blot hybridization.

Authors:  Jairam R Lingappa; William Lawrence; Sheyla West-Keefe; Romesh Gautom; Brad T Cookson
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.